STOCK TITAN

Natural Health Trends (NHTC) Financials

NHTC NASDAQ
Trailing 12 months to September 30, 2026
Revenue $34.1M -16.5% YoY
Net Income -$1.4M n/m YoY
EPS (Diluted) -$0.15 n/m YoY
Free Cash Flow -$4.7M n/m YoY
Market Cap $7.4M as of Oct 27, 2026
Price / Sales 0.2x on $34.1M revenue, trailing 12 months to September 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2026
Price / Book 0.5x on $15.0M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 27, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 28, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NHTC SEC filings page.

Natural Health Trends Corp. (NHTC) reported $34.1M in revenue over the twelve months to Sep 30, 2026, down 16.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NHTC FY2025

Sales have contracted while overhead stayed heavy, and dividends accompanied a shift from modest cash generation to cash consumption.

Gross margin stayed broadly stable, but SG&A increased from 29.7% of revenue in FY2021 to 37.1% in FY2025, indicating that the operating shortfall is increasingly tied to overhead absorption rather than product-level economics.

In FY2025, a net loss of $882K coincided with operating cash outflow of $6.0M, a much wider cash-to-earnings gap than accounting profit alone suggests. With capital expenditures of only $68K, the shortfall mainly reflects ongoing operations rather than heavy reinvestment.

Assets and liabilities both contracted sharply in FY2025, with liabilities declining slightly faster than assets; the balance sheet therefore reflects contraction rather than expansion. Current liquidity remained at 2.5x, while reported liquidity equaled 57.8 months of the latest annual operating outflow alongside $9.2M of dividends.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 34 / 100
Financial Health Score 34/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Natural Health Trends Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
25

Natural Health Trends Corp. has an operating margin of -4.5%, meaning the company loses $5 on every $100 of revenue. This results in a profitability score of 25/100. This is down from -3.0% the prior year.

Growth
17

Natural Health Trends Corp.'s revenue declined 7.4% year-over-year, from $43.0M to $39.8M. This contraction results in a growth score of 17/100.

Leverage
55
Liquidity
70

With a current ratio of 2.50, Natural Health Trends Corp. holds $2.50 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 70/100.

Cash Flow
12

Natural Health Trends Corp.'s operations used $6.0M of cash, and capex of $68K added to the outflow, for a free cash flow shortfall of $6.1M. This results in a cash flow score of 12/100.

Returns
24

Natural Health Trends Corp. posts a -3.8% return on equity (ROE), meaning it loses $4 for every $100 of shareholders' equity. This results in a returns score of 24/100. This is down from 1.7% the prior year.

Altman Z-Score Distress
0.49

Natural Health Trends Corp. scores 0.49, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $36.4M against total assets of $38.4M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/8

Natural Health Trends Corp. passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). No profitability signals pass, all 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality No Cash Backing
N/A

Natural Health Trends Corp. reported a net loss of $882K while operations used $6.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$7.6M
YoY-20.2%
QoQ-0.6%
5Y CAGR-11.9%
10Y CAGR-20.0%

Natural Health Trends Corp. generated $7.6M in revenue in Q3 2026. This represents a decrease of 20.2% from the same quarter a year earlier. Against the prior quarter it is down 0.6%.

EBITDA
-$243K
YoYn/m
QoQn/m

Natural Health Trends Corp.'s EBITDA was -$243K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$232K
YoYn/m
QoQn/m

Natural Health Trends Corp. reported a net loss of $232K in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.03
YoYn/m
QoQn/m

Natural Health Trends Corp. earned -$0.03 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Free Cash Flow
-$1.1M
YoY-1670.0%
QoQn/m
5Y CAGRn/m

Natural Health Trends Corp. recorded an outflow of $1.1M in free cash flow in Q3 2026, representing a cash shortfall after capex. This represents a decrease of 1670.0% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt
$5.8M
YoY-59.4%
QoQ-38.8%
5Y CAGR-41.5%
10Y CAGR-25.8%

Natural Health Trends Corp. held $5.8M in cash as of Q3 2026; no long-term debt figure is on record for that period.

Shares Outstanding
8M
YoY-26.2%
QoQ-1.0%

Natural Health Trends Corp. had 8M shares outstanding in Q3 2026. This represents a decrease of 26.2% from the same quarter a year earlier. Against the prior quarter it is down 1.0%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
74.2%
YoY+0.4pp
QoQ-1.1pp
5Y change-0.2pp
10Y change-6.6pp

Natural Health Trends Corp.'s gross margin was 74.2% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.1 percentage points.

Operating Margin
-3.7%
YoY+1.6pp
QoQ+4.8pp
5Y change-7.0pp
10Y change-25.2pp

Natural Health Trends Corp.'s operating margin was -3.7% in Q3 2026, reflecting core business profitability. This is up 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.8 percentage points.

Net Margin
-3.1%
YoY+1.5pp
QoQ+2.9pp
5Y change-6.4pp
10Y change-20.8pp

Natural Health Trends Corp.'s net profit margin was -3.1% in Q3 2026, showing the share of revenue converted to profit. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.9 percentage points.

Return on Equity
-1.6%
YoY+0.1pp
QoQ+1.4pp
5Y change-2.3pp
10Y change-19.8pp

Natural Health Trends Corp.'s quarterly ROE was -1.6% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.

Capital Allocation

Share Buybacks
$28K
YoYn/m
QoQn/m

Natural Health Trends Corp. spent $28K on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Capital Expenditures
$7K
YoY-83.7%
QoQ-97.8%
5Y CAGR-17.2%
10Y CAGR-26.6%

Natural Health Trends Corp. invested $7K in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 83.7% from the same quarter a year earlier. Against the prior quarter it is down 97.8%.

R&D Spending

Not reported for Q3 2026.

NHTC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NHTC quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$7.6M-20.2%$7.6M-22.5%$9.2M-14.3%$9.7M-10.1%$9.5M-11.4%$9.8M-6.3%$10.7M-2.0%$10.8M-0.8%
Cost of Revenue$2.0M-21.5%$1.9M-26.4%$2.3M-18.7%$2.6M-5.7%$2.5M-9.9%$2.6M-5.2%$2.8M-2.7%$2.8M+0.5%
Gross Profit$5.6M-19.8%$5.7M-21.1%$6.9M-12.7%$7.1M-11.7%$7.0M-11.8%$7.3M-6.7%$7.9M-1.7%$8.0M-1.3%
SG&A Expenses$3.2M-12.0%$3.3M-9.0%$3.5M-6.3%$3.8M-2.6%$3.6M-6.8%$3.6M-6.2%$3.8M-4.0%$3.9M+2.1%
Operating Income-$277Kn/m-$643Kn/m-$474Kn/m-$635Kn/m-$495Kn/m-$333Kn/m-$345Kn/m-$421Kn/m
EBITDA-$243Kn/m-$620Kn/m-$463Kn/m-$613Kn/m-$467Kn/m-$304Kn/m-$315Kn/m-$390Kn/m
Income Tax$67K-52.8%-$2Kn/m-$25Kn/m$175Kn/m$142K+8.4%$0-100.0%-$2K-120.0%-$201K-286.1%
Net Income-$232Kn/m-$451K-3106.7%-$154K-226.2%-$588K-434.1%-$431K-1331.4%$15K-91.3%$122K-35.1%$176K-50.8%
EPS (Basic)-$0.03n/m-$0.05n/m-$0.02-$0.05-350.0%-$0.04n/m$0.00-100.0%$0.01-50.0%$0.02-33.3%
EPS (Diluted)-$0.03n/m-$0.05n/m-$0.02-$0.05-350.0%-$0.04n/m$0.00-100.0%$0.01-50.0%$0.02-33.3%
Diluted Shares (Avg)9M-25.4%9M-25.4%10MN/A12M+0.1%11M+0.1%11M+0.1%N/A

Not reported in any period shown, so not listed: R&D Expenses, Interest Expense.

NHTC Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NHTC quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$27.3M-35.5%$29.2M-35.3%$31.9M-39.9%$38.4M-30.6%$42.3M-27.5%$45.2M-26.6%$53.2M-21.4%$55.4M-19.9%
Current Assets$22.0M-42.0%$23.7M-42.0%$26.5M-45.6%$34.2M-32.9%$37.9M-29.6%$40.9M-28.2%$48.8M-22.2%$51.0M-20.6%
Cash & Equivalents$5.8M-59.4%$9.5M-9.8%$9.2M-57.5%$6.8M-49.7%$14.3M-37.4%$10.5M-32.4%$21.7M-16.0%$13.5M-75.9%
Short-Term Investments$11.8M-33.4%$9.1M-61.5%$12.0M-40.6%$22.1M-27.5%$17.7M-24.6%$23.7M-28.3%$20.2M-29.4%$30.4Mn/m
Inventory$2.1M-4.8%$2.0M-26.0%$2.0M-30.0%$2.0M-37.4%$2.2M-41.5%$2.8M-34.8%$2.8M-42.5%$3.3M-23.8%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Liabilities$12.3M-23.9%$14.0M-14.1%$15.5M-30.5%$15.0M-33.3%$16.1M-29.9%$16.3M-32.7%$22.3M-21.1%$22.5M-18.2%
Current Liabilities$10.3M-30.0%$11.9M-20.1%$13.2M-36.2%$13.7M-34.2%$14.8M-30.1%$14.9M-32.5%$20.7M-0.6%$20.8M+4.1%
Non-Current Liabilities$1.9M+43.1%$2.1M+52.4%$2.2M+44.3%$1.3M-22.3%$1.3M-28.1%$1.4M-35.7%$1.6M-79.0%$1.7M-77.5%
Total Equity$15.0M-42.6%$15.2M-47.3%$16.5M-46.7%$23.4M-28.7%$26.1M-25.9%$28.9M-22.5%$30.9M-21.6%$32.9M-21.0%
Retained Earnings-$39.0Mn/m-$38.8Mn/m-$37.4Mn/m-$36.4Mn/m-$33.5Mn/m-$30.8Mn/m-$28.5Mn/m-$26.3Mn/m

Not reported in any period shown, so not listed: Accounts Receivable, Goodwill, Long-Term Debt.

NHTC Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NHTC quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow-$1.1M-1066.4%-$1.4Mn/m-$797K-264.7%-$959K-1189.8%$113Kn/m-$5.6Mn/m$484K-11.8%$88Kn/m
Depreciation & Amortization$34K+21.4%$23K-20.7%$11K-63.3%$22K-29.0%$28K-9.7%$29K-14.7%$30K-14.3%$31K-8.8%
Stock-Based CompensationN/AN/A$0-100.0%N/AN/AN/A$34K-8.1%N/A
Capital Expenditures$7K-83.7%$325K+8025.0%$115K+618.8%$5K-75.0%$43K+514.3%$4K-78.9%$16K+45.5%$20K+42.9%
Free Cash Flow-$1.1M-1670.0%-$1.7Mn/m-$912K-294.9%-$964K-1517.6%$70Kn/m-$5.6Mn/m$468K-13.0%$68Kn/m
Investing Cash Flow-$2.6M-144.3%$2.5Mn/m$9.9M-0.3%-$4.4Mn/m$5.9M-39.8%-$3.3Mn/m$10.0Mn/m-$7.0Mn/m
Financing Cash Flow-$28Kn/m-$858Kn/m-$6.7Mn/m-$2.3Mn/m-$2.3Mn/m-$2.3Mn/m-$2.3Mn/m-$2.3Mn/m
Dividends Paid$0-100.0%$858K-62.7%$858K-62.7%$2.3M-0.1%$2.3M0.0%$2.3M0.0%$2.3M0.0%$2.3M0.0%
Share Buybacks$28Kn/m$0n/m$5.9Mn/mN/A$0$0$0N/A

NHTC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NHTC quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin74.2%+0.4pp75.3%+1.3pp75.0%+1.4pp72.9%-1.3pp73.7%-0.4pp73.9%-0.3pp73.6%+0.2pp74.2%-0.3pp
Operating Margin-3.7%+1.6pp-8.5%-5.1pp-5.1%-1.9pp-6.5%-2.6pp-5.2%-2.7pp-3.4%-1.1pp-3.2%+0.1pp-3.9%-1.7pp
Net Margin-3.1%+1.5pp-5.9%-6.1pp-1.7%-2.8pp-6.0%-7.6pp-4.5%-4.9pp0.1%-1.5pp1.1%-0.6pp1.6%-1.7pp
Return on Equity-1.6%+0.1pp-3.0%-3.0pp-0.9%-1.3pp-2.5%-3.0pp-1.7%-1.8pp0.1%-0.4pp0.4%-0.1pp0.5%-0.3pp
Return on Assets-0.9%+0.2pp-1.5%-1.6pp-0.5%-0.7pp-1.5%-1.8pp-1.0%-1.1pp0.0%-0.3pp0.2%-0.1pp0.3%-0.2pp
Current Ratio2.13-0.4x1.99-0.7x2.00-0.3x2.500.0x2.570.0x2.73+0.2x2.35-0.7x2.45-0.8x
Liabilities-to-Equity0.82+0.2x0.92+0.4x0.94+0.2x0.640.0x0.620.0x0.57-0.1x0.720.0x0.680.0x
Asset Turnover0.28+0.1x0.260.0x0.29+0.1x0.25+0.1x0.220.0x0.220.0x0.200.0x0.200.0x
FCF Margin-14.5%-15.3pp-22.2%+35.3pp-9.9%-14.3pp-9.9%-10.5pp0.7%+4.9pp-57.5%-23.2pp4.4%-0.5pp0.6%+1.4pp

Not reported in any period shown, so not listed: Debt-to-Equity.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Natural Health Trends Corp. NHTC FY2025 $39.8M -$882K -2.2% $7.4M 34/100
Oriental Culture Holding LTD OCG FY2025 $1.9M -$3.9M N/A $3.0M 61/100
Hour Loop, Inc. HOUR FY2025 $142.4M $1.7M 1.2% $56.0M 37/100
1stdibs.com, Inc. DIBS FY2025 $89.6M -$13.7M -15.3% $159.3M 73/100
Baozun Inc. BZUN FY2025 $1.4B -$34.6M -2.4% $194.1M 41/100
MOGU Inc. MOGU FY2026 $18.2M $267K 1.5% $16.1M 22/100

Frequently Asked Questions

Back to top